ࡱ> 574 NbjbjVV 4<<N  //// ;/ >WWWWW222y { { { { { { #%B{ 22222{ WW 2RWWy 2y :,W>m/" e  0 .%%%|2222222{ { 222 2222%222222222 : CLINICAL PHARMACOLOGY (September start) (MSc/PgDip with a view to transfer to MSc/PgDip/PgCert) 57B200BT/61B200BT/61B200X5/62B200VZ Qualifications for entry: A degree or equivalent qualification, at the prescribed standard in Medicine, Pharmacology, Pharmacy or a relevant Science subject (e.g. Biochemistry, Biology, Biomedical Science). Duration: 12 months full-time or 24 months part-time (MSc); 9 months full-time (PgDip) Aim: To equip students for careers developing and expanding current knowledge of drugs. To achieve this the programme will provide a multi-disciplinary approach to the study of drug discovery and development; mechanisms of drug action; preclinical and clinical trials; and regulatory affairs. Content: The programme of taught courses will comprise lectures, tutorials, practical classes and directed self-learning. The curriculum includes biochemical and molecular aspects of drug action; drug transport, metabolism and excretion; toxicology; pharmacokinetics; statistics; computing studies; industrial aspects of drug development; therapeutics; therapeutic drug monitoring; the influence of disease on drug handling; drug-drug interactions; the design and conduct of volunteer and clinical trials; monitoring drug safety. Candidates shall be required to attend the following designated programme of courses: Stage 1 GS 50M1 Generic Skills (0 credit points) MT 5003 Drug Metabolism and Toxicology (15 credit points) MT 5004 Therapeutics (10 credit points) MT 5006 Induction Course (5 credit points) MT 5008 Molecular Pharmacology (20 credit points) PU 5005 Applied Statistics (10 credit points) SK 5003 Information Skills (0 credit points) Elective MB 5015 Molecular Biology Basics & Cloning Lab (15 credit points) Stage 2 BT 5901 Laboratory Techniques Core Practical Skills (10 credit points) additional for students taking lab based research projects MT 5501 Pharmacovigilance (5 credit points) MT 5502 Drug Development to Evidence Based Medicine (20 credit points) MT 5503 Pharmacokinetics (10 credit points) and one course chosen with the approval of the Head of the School from a list which will normally include the following: MT 5506 Omics in Research (5 credit points) MT 5701 Gene-nutrient Interactions (5 credit points) Elective BT 5506 Business of Science (5 credit points) MT 55EP Careers & Employability for Postgraduates (5 credit points) Diploma candidates may be allowed to transfer to the MSc if they complete the above programme at an appropriate standard. No candidate will be allowed to progress to Stage 3 as an MSc candidate if they fail to achieve an appropriate standard in the above programme. MSc candidates with a registered medical qualification may be able to carry out a clinical research project in the final stage under supervision of one of the medical staff. Stage 3 MT 5801 Dissertation in Clinical Pharmacology (25 credit points) [Diploma candidates] MT 5802 Research Project in Clinical Pharmacology (80 credit points) [MSc candidates] Assessment: By practical work, by written essays and by oral presentations, or by a combination of these, as prescribed for each course. The project and dissertation will be assessed and there will usually be an oral examination on completion of the programme. Candidates must pass all courses at an appropriate standard for the award of the MSc degree. b l Q X 18LMNɶ h-hCJhx;h[!OJQJ^JaJ%hx;hx;56>*CJOJQJaJhx;hx;>*OJQJaJhx;hx;5OJQJaJhx;hx;6OJQJaJhx;hx;OJQJaJka b P Q Y Z Bp gdx; $ 0a$gdx; 0gdx;  9r gdx;  D%dgdx;  6$dgdx;x1u gdx; 0*`gdx; gdx; 0*gdx; 0*gdx; 0gdx;uv019:MNgd-  9r 0gdx; 0`gdx; gdx; 0gdx; $ 0a$gdx; 21h:p[=. A!"#$% j 666666666vvvvvvvvv66666>66666666666666666666666666666666666666666666666hH6666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ OJPJQJ_HmH nH sH tH N`N  Normal$a$ CJOJPJQJ_HmH sH tH `@` + Heading 2$<@&$56CJOJPJQJ\]^JaJ>@>   Heading 3$d8@&5XX = Heading 6 <@&5CJOJPJQJ\^JaJRR "2^ Heading 7 <@&CJOJPJQJ^JaJXX N$ Heading 8 <@&6CJOJPJQJ]^JaJDA D Default Paragraph FontRiR 0 Table Normal4 l4a (k ( 0No List PP  Heading 3 Char5CJOJPJQJ^JaJ\\ +Heading 2 Char(56CJOJPJQJ\]^JaJtH 4@4 +Header  9r B!B + Header CharCJOJPJQJtH V1V =Heading 6 Char"5CJOJPJQJ\^JaJtH PAP "2^Heading 7 CharCJOJPJQJ^JaJtH JZRJ w0 Plain Text$a$CJOJQJ^JtH FaF w0Plain Text CharOJPJQJ^JVQrV ft Body Text 3$ 0d6a$ 5OJQJPP ftBody Text 3 Char5CJOJPJQJtH VV N$Heading 8 Char"6CJOJPJQJ]^JaJtH 6U6 mO Hyperlink >*B*phPK![Content_Types].xmlj0Eжr(΢Iw},-j4 wP-t#bΙ{UTU^hd}㨫)*1P' ^W0)T9<l#$yi};~@(Hu* Dנz/0ǰ $ X3aZ,D0j~3߶b~i>3\`?/[G\!-Rk.sԻ..a濭?PK!֧6 _rels/.relsj0 }Q%v/C/}(h"O = C?hv=Ʌ%[xp{۵_Pѣ<1H0ORBdJE4b$q_6LR7`0̞O,En7Lib/SeеPK!kytheme/theme/themeManager.xml M @}w7c(EbˮCAǠҟ7՛K Y, e.|,H,lxɴIsQ}#Ր ֵ+!,^$j=GW)E+& 8PK!Ptheme/theme/theme1.xmlYOo6w toc'vuر-MniP@I}úama[إ4:lЯGRX^6؊>$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3ڗP 1Pm \\9Mؓ2aD];Yt\[x]}Wr|]g- eW )6-rCSj id DЇAΜIqbJ#x꺃 6k#ASh&ʌt(Q%p%m&]caSl=X\P1Mh9MVdDAaVB[݈fJíP|8 քAV^f Hn- "d>znNJ ة>b&2vKyϼD:,AGm\nziÙ.uχYC6OMf3or$5NHT[XF64T,ќM0E)`#5XY`פ;%1U٥m;R>QD DcpU'&LE/pm%]8firS4d 7y\`JnίI R3U~7+׸#m qBiDi*L69mY&iHE=(K&N!V.KeLDĕ{D vEꦚdeNƟe(MN9ߜR6&3(a/DUz<{ˊYȳV)9Z[4^n5!J?Q3eBoCM m<.vpIYfZY_p[=al-Y}Nc͙ŋ4vfavl'SA8|*u{-ߟ0%M07%<ҍPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 +_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!Ptheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] N N uN 8@0(  B S  ?-2RWX^P  (P 33L M P L M P zp>}z<<^<`o(.^`o(()zLz^z`L.J J ^J `.  ^ `.L^`L.^`.^`.ZLZ^Z`L. ^`OJQJo(^`OJQJ^Jo(o pp^p`OJQJo( @ @ ^@ `OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o PP^P`OJQJo(}zzp         YV BkwgH J&d =gu(,v[!)"Z%l.3g8x;[=Q@B|BCJqKLyLw}MmOk,QEuW^]"2^H_a;aMVataEcFe%'gQ=gy&jDzj\Al9o(tftvYxH y%z7g|4&}?7}sl a=w ~(u.t9aj+M7R.~N$h-mO|5$mg;Sdz9B}%R9gN P @N h@Unknown G*Ax Times New Roman5Symbol3. *Cx Arial7.{ @CalibriY CG TimesTimes New Roman7K@Cambria?= *Cx Courier New;WingdingsA BCambria Math"qh=f=fR R !20H H 3HP $P 2!xxRobertRobert  Oh+'0 px  RobertNormalRobert2Microsoft Office Word@@-m@-mR ՜.+,0 hp|  H   Title  !"#%&'()*+-./01236Root Entry F>m81Table &WordDocument4SummaryInformation($DocumentSummaryInformation8,CompObjy  F'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.89q